Turkey’s own covid-19 vaccine (Turkovac) standins witness for how impressive Turkey's health system has improved. The Turkish government was able to respond ideally to the Covid-19 pandemic by developing and improving Turkey’s own covid-19 vaccine (Turkovac). Given the considerable Turkish government investment in the Turkish health sector, which started from about the past 20 years, the health sector was invested in each government and private hospital, which witnessed a vast improvement in terms of services and medicines, and health insurance system for both Turks and foreigners together. Read more - All you need to know about Turkey's private hospitals
Professor Erhan Ak Dogan, Head of Health Institutes in Turkey, said that the country has coped well with the Covid-19 epidemic and that the preparations and investments made in the health sector over the past twenty years have paid off, both in combating the pandemic and in producing the local vaccine against it.
Professor Erhan Ak Dogan added that Turkey is considered as one of nine countries that managed to produce a vaccine. He also emphasized that the vital infrastructure in many divisions of life, developed and modernized in the past 20 years, has borne fruit during this pandemic.
The positive results of the durability of the Turkish economy and infrastructure were apparent through the Turkish government's dealings with the Turkish nation, by securing and paying salaries to both the employees and workers in the governmental sector, who were affected by the pandemic, and also in the private sector, the work by the Turkish government accomplished to secure monthly salaries and expenses in agreement with the private and the joint industry, through creating new laws in collaboration with government and private insurance companies.
Professor Erhan Ak Dogan noted that thanks to Turkey's large and stable Gross domestic product (GDP), which spent more than one billion Turkish liras for citizens during the pandemic, the pandemic was controlled without leaving any adverse effects on the lives of Turkish citizens and even improving their living conditions.
Also stressed that Turkey could support its citizens and produce all medical supplies locally. Thanks to the robust infrastructure of Turkish medical laboratories, Turkey resulted in a considerable surplus. Turkey was able to help neighboring countries affected by the effects of the pandemic, such as Italy, Lebanon, Sudan, Libya, Yemen, Azerbaijan, And many more.
In the first stage, a study is conducted on whether the vaccine is safe or not by trying it on dozens of volunteers. After the tests conducted by scientists and verifying the vaccine's safety, it is agreed to move to the second stage of the vaccine production stages.
In the second stage, studies are conducted on the vaccine's effectiveness on more significant numbers, including hundreds of volunteers. After the approval of local authorities and scientific research ethics committees on its effectiveness, the third stage begins in which safety and efficacy are examined together.
After proving the safety and effectiveness of the "Turkovac" vaccine, studies began in the third phase, which included the application of the vaccine to a large segment of people last June.
The Turkovac vaccine holds significant importance and meaning as Turkey's very own contribution to responding to the COVID-19 global outbreak. Generated and developed national as a result of long term investment in the health sector, Turkovac symbolizes Turkey's capability to respond effectively to public health crises and reduce reliance on foreign vaccines.
Indeed, the Turkovac vaccine has been under intense clinical testing to ensure the safety and efficacy of the Turkovac vaccine. The testing process followed the internationally recognized protocols. As the procedures included preclinical studies on animals and subsequent human trials in multiple phases. These trials assess both the safety and effectiveness of the vaccine before its widespread distribution.
The testing process followed the internationally recognized protocols. As the procedures included preclinical studies on animals and subsequent human trials in multiple phases. These trials assess both the safety and effectiveness of the vaccine before its widespread distribution.
The vaccine does not only meetu Turkey’s needs for the COVID-19 Vassine to it’s own nation but also it serves witness as the country’s biotechnology development. It is a prove of Turkey’s ability to innovate and create.
The Turkovac vaccine's development and distribution have been made possible by Turkey's substantial, long-term investments made in its health sector over the previous 20 years. In order to successfully create and deploy Turkovac to battle COVID-19, this investment comprises the formation of medical research institutes, modernization of healthcare infrastructure, and implementation of cutting-edge healthcare technologies.